Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 13 matching records.
13 results — page 1 of 1
- Level BRandomized Controlled TrialPubMed
Safety and efficacy of an allogeneic adipose-derived mesenchymal stem cell preparation in the treatment of knee osteoarthritis: A Phase I/IIa randomised controlled trial.
Randomized Controlled Trial with a reported sample of 40 on Knee Osteoarthritis, Osteoarthritis, published in Osteoarthr Cartil Open (2024) — summary generated from the PubMed abstract.
- 2024
- n = 40
Osteoarthr Cartil Open10 citations - Level CCase Report / SeriesPubMed
Real-world evidence of mesenchymal stem cell therapy in knee osteoarthritis: a large prospective two-year case series.
Case Report / Series with a reported sample of 329 on Knee Osteoarthritis, Osteoarthritis, published in Regen Med (2022) — summary generated from the PubMed abstract.
- 2022
- n = 329
Regen Med16 citations - Level BClinical TrialPubMed
Effect of autologous adipose-derived mesenchymal stem cell therapy in combination with autologous platelet-rich plasma in the treatment of elbow tendinopathy.
Clinical Trial on Tendon Injury, Chronic Inflammation, published in BMJ Case Rep (2020) — summary generated from the PubMed abstract.
- 2020
BMJ Case Rep12 citations - Level BClinical TrialPubMed
Effect of autologous adipose-derived mesenchymal stem cell therapy in the treatment of an osteochondral lesion of the ankle.
Clinical Trial on Osteoarthritis, Cartilage Damage, Ankle Injury, published in BMJ Case Rep (2020) — summary generated from the PubMed abstract.
- 2020
BMJ Case Rep13 citations - Level CCase Report / SeriesPubMed
Evaluation of autologous adipose-derived mesenchymal stem cell therapy in focal chondral defects of the knee: a pilot case series.
Case Report / Series on Osteoarthritis, Cartilage Damage, published in Regen Med (2020) — summary generated from the PubMed abstract.
- 2020
Regen Med - Level CCase Report / SeriesPubMed
Mesenchymal stem cell therapy combined with arthroscopic abrasion arthroplasty regenerates cartilage in patients with severe knee osteoarthritis: a case series.
Case Report / Series with a reported sample of 27 on Knee Osteoarthritis, Osteoarthritis, Cartilage Damage, published in Regen Med (2020) — summary generated from the PubMed abstract.
- 2020
- n = 27
Regen Med - Level CProspective StudyPubMed
High tibial osteotomy in combination with arthroscopic abrasion arthroplasty and autologous adipose-derived mesenchymal stem cell therapy in the treatment of advanced knee osteoarthritis.
Prospective Study on Knee Osteoarthritis, Osteoarthritis, Cartilage Damage, published in BMJ Case Rep (2019) — summary generated from the PubMed abstract.
- 2019
BMJ Case Rep8 citations - Level BRandomized Controlled TrialPubMed
Adipose-derived mesenchymal stem cell therapy in the treatment of knee osteoarthritis: a randomized controlled trial.
Randomized Controlled Trial with a reported sample of 30 on Knee Osteoarthritis, Osteoarthritis, published in Regen Med (2019) — summary generated from the PubMed abstract.
- 2019
- n = 30
Regen Med - Level BClinical TrialPubMed
Effect of autologous adipose-derived mesenchymal stem cell therapy in the treatment of acromioclavicular joint osteoarthritis.
Clinical Trial on Knee Osteoarthritis, Osteoarthritis, Cartilage Damage, Shoulder Pain, published in BMJ Case Rep (2019) — summary generated from the PubMed abstract.
- 2019
BMJ Case Rep14 citations - Level BClinical TrialPubMed
The effect of autologous adipose derived mesenchymal stem cell therapy in the treatment of a large osteochondral defect of the knee following unsuccessful surgical intervention of osteochondritis dissecans - a case study
Clinical Trial on Osteoarthritis, Cartilage Damage, published in BMC Musculoskelet Disord (2017) — summary generated from the PubMed abstract.
- 2017
BMC Musculoskelet Disord25 citations - Level CProspective StudyPubMed
Effect of autologous adipose-derived mesenchymal stem cell therapy in the treatment of a post-traumatic chondral defect of the knee.
Prospective Study on Osteoarthritis, Cartilage Damage, published in BMJ Case Rep (2017) — summary generated from the PubMed abstract.
- 2017
BMJ Case Rep18 citations - Level BClinical TrialEurope PMC
Mesenchymal stem cell therapy in the treatment of osteoarthritis: reparative pathways, safety and efficacy - a review
Clinical Trial on Knee Osteoarthritis, Osteoarthritis, Cartilage Damage, published in BMC Musculoskelet Disord (2016) — summary generated from the PubMed abstract.
- 2016
BMC Musculoskelet Disord171 citations - Level BRandomized Controlled TrialPubMed
Adipose derived mesenchymal stem cell therapy in the treatment of isolated knee chondral lesions: design of a randomised controlled pilot study comparing arthroscopic microfracture versus arthroscopic microfracture combi
Randomized Controlled Trial with a reported sample of 40 on Osteoarthritis, Cartilage Damage, published in BMJ Open (2015) — summary generated from the PubMed abstract.
- 2015
- n = 40
BMJ Open43 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406